Access Bio Past Earnings Performance

Past criteria checks 0/6

Access Bio has been growing earnings at an average annual rate of 14.1%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 25% per year.

Key information

14.1%

Earnings growth rate

14.5%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate25.0%
Return on equity-2.8%
Net Margin-15.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem

Mar 26
Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem

Recent updates

Optimistic Investors Push Access Bio, Inc. (KOSDAQ:950130) Shares Up 38% But Growth Is Lacking

Aug 07
Optimistic Investors Push Access Bio, Inc. (KOSDAQ:950130) Shares Up 38% But Growth Is Lacking

Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem

Mar 26
Access Bio's (KOSDAQ:950130) Earnings Are Weaker Than They Seem

Is Access Bio (KOSDAQ:950130) A Risky Investment?

Mar 25
Is Access Bio (KOSDAQ:950130) A Risky Investment?

If You Had Bought Access Bio (KOSDAQ:950130) Shares A Year Ago You'd Have Earned 740% Returns

Feb 18
If You Had Bought Access Bio (KOSDAQ:950130) Shares A Year Ago You'd Have Earned 740% Returns

Revenue & Expenses Breakdown

How Access Bio makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A950130 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24101,330-15,65242,47511,653
31 Mar 24141,282-42,21858,84014,292
31 Dec 23348,643-3,173130,25716,081
30 Sep 23361,1776,908152,26117,305
30 Jun 23370,519-2,101161,86515,418
31 Mar 23452,09499,507166,7139,878
31 Dec 221,033,863346,670342,4717,316
30 Sep 221,205,808418,017374,5506,125
30 Jun 221,234,194452,910365,1525,739
31 Mar 221,103,446356,212373,2155,277
31 Dec 21505,112189,690130,3704,894
30 Sep 21374,187168,03476,1864,371
30 Jun 21344,042151,25670,5514,278
31 Mar 21338,051171,59333,0314,284
31 Dec 20121,79748,27218,9144,006
30 Sep 2040,472-23013,8113,188
30 Jun 2042,118-14,56719,0922,950
31 Mar 2042,755-17,21818,9082,536
31 Dec 1943,059-17,58818,2832,200
30 Sep 1941,675-18,98418,5462,394
30 Jun 1938,944-7,13413,1882,326
31 Mar 1939,874-5,22614,8772,646
31 Dec 1840,239-4,24115,5452,934
30 Sep 1840,283-4,47714,6062,458
30 Jun 1840,535-4,94115,1892,564
31 Mar 1834,392-5,46013,1412,370
31 Dec 1729,465-6,48612,7301,942
30 Sep 1727,348-4,51112,8722,041
30 Jun 1725,438-3,40812,2881,745
31 Mar 1729,884-1,64312,5791,498
31 Dec 1632,48630412,4181,510
30 Sep 1633,6891,79411,7821,351
30 Jun 1632,2112,45711,0581,311
31 Mar 1633,0622,01210,4621,090
31 Dec 1535,5831,2659,935971
30 Sep 1530,4926209,682967
30 Jun 1532,6692439,288896
31 Mar 1532,7341,1999,532828
31 Dec 1432,3052,43212,106815
30 Sep 1442,4895,30712,985797
30 Jun 1445,1267,61113,493655
31 Mar 1446,8748,10113,494566
31 Dec 1345,8407,83811,838415

Quality Earnings: A950130 is currently unprofitable.

Growing Profit Margin: A950130 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A950130 is unprofitable, but has reduced losses over the past 5 years at a rate of 14.1% per year.

Accelerating Growth: Unable to compare A950130's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A950130 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4%).


Return on Equity

High ROE: A950130 has a negative Return on Equity (-2.78%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies